Keratinocyte carcinoma prevention with nicotinamide was cost-effective and patient-centered, reducing treatment costs and providing measurable quality-of-life benefit. ja.ma/4v43xjl
Pediatric patients waited 68% longer for appointments with pediatric dermatologists than with general dermatologists, and >30% of general dermatologists did not accept new pediatric patients. ja.ma/442Y7ZJ
An adolescent boy presented with more than 10-year history of skin discoloration and difficulty protruding the tongue. What is your diagnosis? Take the JAMA Dermatology Clinical Challenge: ja.ma/4e1kOn3
#HidradenitisSuppurativa is associated with increased risks of self-harm and suicide, highlighting the importance of clinician vigilance and multidisciplinary mental health support. ja.ma/4ehM1Rt
No significant difference in melanoma mortality trends was observed between Germany's #SkinCancerScreening program and neighboring countries, suggesting limited population-level impact. ja.ma/3PWjUPE
Keratinocyte carcinoma prevention with nicotinamide was cost-effective and patient-centered, reducing treatment costs and providing measurable quality-of-life benefit. ja.ma/4e9TYJH
No significant difference in melanoma mortality trends was observed between Germany's #SkinCancerScreening program and neighboring countries, suggesting limited population-level impact. ja.ma/43YQbIX
No significant difference in melanoma mortality trends was observed between Germany's #SkinCancerScreening program and neighboring countries, suggesting limited population-level impact. ja.ma/3QBvakB
Among adults with refractory #HidradenitisSuppurativa, golimumab led to durable improvement in disease severity; most responders used doses of 200–300 mg every 3–4 weeks. ja.ma/4ehcBKq
Joachim Hübner, PhD, and Alexander Katalinic, MD, discuss recent findings comparing #melanoma mortality rates in Germany from 2009 to 2022 with those in nine neighboring countries without population-wide screening programs.
🎧 Listen to the podcast:
ja.ma/3Qy67Pp
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
JAMA Dermatology
Interview with Joachim Hübner, MD, SJD, and Alexander Katalinic, MD, authors of Population Skin Cancer Screening and Melanoma Mortality Rates. Hosted by Adewole S. Adamson, MD, MPP.
